These data are an indicator of children younger that 6 years of age tested in NYC in a given year with blood lead levels of 5 mcg/dL or greater. About the Data All NYC children are required to be tested for lead poisoning at around age 1 and age 2, and to be screened for risk of lead poisoning, and tested if at risk, up until age 6. These data are an indicator of children younger that 6 years of age tested in NYC in a given year with blood lead levels of 5 mcg/dL or greater. In 2012, CDC established that a blood lead level of 5 mcg/dL is the reference level for exposure to lead in children. This level is used to identify children who have blood lead levels higher than most children's levels. The reference level is determined by measuring the NHANES blood lead distribution in US children ages 1 to 5 years, and is reviewed every 4 years.

This dataset contains lead blood levels, by Census Tract, for the state of Michigan in 2017. An elevated blood lead level (EBLL) was defined by blood lead levels above 4.5 micrograms of lead per deciliter of blood (μg/dL). Data Driven Detroit received lead blood level test results for individuals in the state from Michigan Department of Health and Human Services, and then aggregated the data to anonymize results. Areas with null values represent no blood lead level testing or numbers that have been suppressed (less than 6) to protect the tested individuals.,

As of January 1, 2009, Connecticut law mandates that medical providers must conduct annual lead screening (i.e., blood lead testing) for each child 9 to 35 months of age. Furthermore, the law requires that any child between 36-72 months of age who has not been previously tested must also be tested by the child’s medical provider, regardless of risk. This dataset includes the 10-year prevalence in Connecticut's top five cities.

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024 Children Receiving Blood Lead Screening - This indicator reflects the percentage of children (aged 12-35 months) enrolled in Medicaid (90+ days) screened for lead in their blood. Each pediatric Medicaid enrollee should be screened for blood lead during their 12 and 24-month well child visit. Common sources of pediatric lead exposure include dust and paint chips from chipping or peeling lead paint, as well as lead contaminated: soil, toys, water, cosmetics, and folk medicines. Link to Data Details

Relationship Between Total and Biaccessible Lead on Children's Blood Lead Levles in Urban Residential Philadelphia Soils. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: These data are from a human study collected under IRB protocol: Institutional Review Board approval was obtained from both the Centers for Disease Control and Prevention (CDC IRB Approval #6611, "John T. Lewis Community Childhood Blood Lead Prevalence and Health Housing) and the Philadelphia Department of Public Health (PDPH). As such, it is a violation of Federal Law to publish them. Format: These data are from a Regional study in Philadelphia. Institutional Review Board approval was obtained from both the Centers for Disease Control and Prevention and the Philadelphia Department of Public Health (PDPH). This dataset is associated with the following publication: Bradham, K., C. Nelson, J. Kelly, A. Pomales, K. Scruto, T. Dignam, J. Misenheimer, K. Li, D. Obenour, and D. Thomas. Relationship Between Total and Bioaccessible Lead on Children’s Blood Lead Levels in Urban Residential Philadelphia Soils. ENVIRONMENTAL SCIENCE & TECHNOLOGY. American Chemical Society, Washington, DC, USA, 51(17): 10005-10011, (2017).

Relationship Between Total and Biaccessible Lead on Children's Blood Lead Levles in Urban Residential Philadelphia Soils. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: These data are from a human study collected under IRB protocol: Institutional Review Board approval was obtained from both the Centers for Disease Control and Prevention (CDC IRB Approval #6611, "John T. Lewis Community Childhood Blood Lead Prevalence and Health Housing) and the Philadelphia Department of Public Health (PDPH). As such, it is a violation of Federal Law to publish them. Format: These data are from a Regional study in Philadelphia. Institutional Review Board approval was obtained from both the Centers for Disease Control and Prevention and the Philadelphia Department of Public Health (PDPH). This dataset is associated with the following publication: Bradham, K., C. Nelson, J. Kelly, A. Pomales, K. Scruto, T. Dignam, J. Misenheimer, K. Li, D. Obenour, and D. Thomas. Relationship Between Total and Bioaccessible Lead on Children’s Blood Lead Levels in Urban Residential Philadelphia Soils. ENVIRONMENTAL SCIENCE & TECHNOLOGY. American Chemical Society, Washington, DC, USA, 51(17): 10005-10011, (2017).